Editorial Material
Cardiac & Cardiovascular Systems
Rafael Romaguera, Gerard Roura, Alex Ruiz-Majoral, Angel Sanchez-Recalde, Carles Diez-Lopez, Daniel Fontes-Carame, Josep Comin-Colet, Joan A. Gomez-Hospital
Summary: There is supplemental digital content available in the text for reference.
CIRCULATION-HEART FAILURE
(2021)
Review
Cardiac & Cardiovascular Systems
Antonio Mangieri, Alessandro Sticchi, Aisha Gohar, Damiano Regazzoli, Fabio Fazzari, Daniela Pini, Marta Pellegrino, Beniamino Pagliaro, Ferdinando Loiacono, Mauro Chiarito, Bernhard Reimers, Fabien Praz, Azeem Latib, Antonio Colombo
Summary: Tricuspid regurgitation has a negative impact on patient outcomes, and surgical treatment is not suitable for high-risk patients. Percutaneous approaches offer a viable and lower-risk alternative, with several devices currently under development.
REVIEWS IN CARDIOVASCULAR MEDICINE
(2022)
Review
Cardiac & Cardiovascular Systems
Besart Cuko, Massimo Baudo, Olivier Busuttil, Saud Taymoor, Karine Nubret, Stephane Lafitte, Antoine Beurton, Alexandre Ouattara, Carlo De Vincentiis, Thomas Modine, Louis Labrousse, Mathieu Pernot
Summary: This study reviewed the surgical management of severe tricuspid regurgitation through tricuspid valve replacement after heart transplantation. The findings suggest that tricuspid valve replacement with a bioprosthesis may be the optimal solution for these patients.
HEART FAILURE REVIEWS
(2023)
Article
Cardiac & Cardiovascular Systems
Erwan Donal, Guillaume Leurent, Anne Ganivet, Philip Lurz, Augustin Coisne, Pascal De Groote, Stephane Lafitte, Lionel Leroux, Nicole Karam, Loic Biere, Frederic Rouleau, Catherine Sportouch, Julien Dreyfus, Mohammed Nejjari, Jean-Michel Josselin, Amedeo Anselmi, Elena Galli, Emma Bajeux, Patrice Guerin, Jean-Francois Obadia, Jean-Noel Trochu, Emmanuel Oger
Summary: The Tri.fr trial is a multicentre, randomized controlled study aiming to investigate the impact of non-surgical treatment for tricuspid regurgitation on clinical outcomes. The study will follow 300 patients with severe secondary TR and use the Packer composite clinical endpoint as the primary outcome measure.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING
(2022)
Article
Cardiac & Cardiovascular Systems
Abdurashid Mussayev, Serik Alimbayev, Nursultan Tanaliev, Aidyn Kuanyshbek, Aripov Marat, Timur Lesbekov, Yerkezhan Raissov, Aigerim Sadykova, Askarovna Kenzhebayeva Kamila, Murat Mukarov, Yuriy Pya
Summary: A case-series was presented on the use of a novel balloon-expandable transcatheter heart valve for tricuspid valve-in-valve procedures. This approach, which involves implanting the valve onto the deteriorated bioprosthetic valve, has shown promising results in improving tricuspid valve dysfunction. The study outlines the procedural steps and challenges faced during these interventions, aiming to prevent adverse events and reduce early mortality rates.
FRONTIERS IN CARDIOVASCULAR MEDICINE
(2023)
Article
Cardiac & Cardiovascular Systems
Brian Karahalios, John P. Breinholt, Stephen H. Little, C. Huie Lin
Summary: Transcatheter valve-in-valve implantation can reduce the need for surgical reinterventions in some patients with congenital heart disease, but may lead to patient-prosthesis mismatch in others. Fracturing the bioprosthetic valve ring to optimize hemodynamics during implantation of a transcatheter valve could be an effective strategy.
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
(2021)
Article
Cardiac & Cardiovascular Systems
Fabian Barbieri, Mark Schroeder, Niklas Beyhoff, Ulf Landmesser, Markus Reinthaler, Mario Kasner
Summary: The case report presents a successful percutaneous edge-to-edge tricuspid valve repair in a 78-year-old female with significant tricuspid regurgitation. Despite the presence of an additional membrane, the patient's symptoms improved after the implantation of 3 clips. Accurate echocardiographic visualization is crucial for accessing the tricuspid valve without complications.
JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE
(2021)
Article
Cardiac & Cardiovascular Systems
Peng Liu, Dong-Sheng Xia, Wei-Hua Qiao, Dan Hu, Adnan Ahmed, Nian-Guo Dong, Si Chen
Summary: This study compared the long-term outcomes of mechanical and biological prostheses in patients undergoing isolated or combined tricuspid valve replacement. The results suggest that biological prostheses may be the optimal choice for isolated tricuspid valve replacement, especially for patients without Ebstein's anomaly.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
(2021)
Review
Cardiac & Cardiovascular Systems
Bhaskar Bhardwaj, Joaquin E. Cigarroa, Firas Zahr
Summary: This review focuses on the currently available transcatheter tricuspid valve therapies, device selection, and the management of tricuspid regurgitation (TR) in the context of other transcatheter valvular procedures. It highlights the underrecognition and undertreatment of TR, and the reassuring effectiveness and safety of transcatheter devices for tricuspid repair and replacement in clinical trials.
CURRENT CARDIOLOGY REPORTS
(2022)
Article
Cardiac & Cardiovascular Systems
Michael Dismorr, Natalie Glaser, Anders Franco-Cereceda, Ulrik Sartipy
Summary: Prosthesis-patient mismatch (PPM) is common after surgical aortic valve replacement (SAVR). Increasing grades of PPM are associated with long-term mortality and severe PPM is associated with increased heart failure. Moderate PPM is common, but the clinical significance may be negligible.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
(2023)
Article
Cardiac & Cardiovascular Systems
Jingwei Feng, Yingjiao Wang, Shiyu Cheng, Zishuo Liu, Ling Lan, Qi Miao, Chaoji Zhang
Summary: Axenfeld-Rieger syndrome (ARS) is an autosomal dominant disorder caused by disruption of neural crest cell development. ARS is characterized by associated symptoms in both eyes accompanied by extraocular developmental defects. This case report describes a 17-year-old girl with ARS presenting with typical facial malformations and severe mitral and tricuspid valve insufficiency. Echocardiography revealed severe valve insufficiency, providing further evidence of the association between ARS and cardiac malformations.
FRONTIERS IN CARDIOVASCULAR MEDICINE
(2022)
Article
Cardiac & Cardiovascular Systems
Hidefumi Nishida, Valluvan Jeevanandam, Christopher Salerno, Atsushi Nemoto, Tae Song, David Onsager, Ann Nguyen, Jonathan Grinstein, Bow Chung, Nitasha Sarswat, Gene Kim, Sean Pinney, Takeyoshi Ota
Summary: Prophylactic donor heart tricuspid valve annuloplasty has the potential to reduce the occurrence of significant TR and can be performed safely. The development of significant TR in patients with prophylactic annuloplasty negatively affected survival and was an independent predictor of long-term mortality.
JOURNAL OF CARDIOTHORACIC SURGERY
(2023)
Review
Cardiac & Cardiovascular Systems
Joel P. Giblett, Lynne K. Williams, Narain Moorjani, Patrick A. Calvert
Summary: Paravalvular leak (PVL) is a challenging complication of valve replacement surgery, with surgical repair and percutaneous closure being the two main treatment options. While both methods show comparable technical success, percutaneous closure may reduce short-term mortality and offer similar long-term outcomes compared to surgical repair. More prospective studies are needed to validate the role of percutaneous closure in the armamentarium of the heart team.
Review
Medicine, General & Internal
Marcio Jose Montenegro da Costa, Edgard Freitas Quintella, Luiz Kohn, Maximiliano Otero Lacoste, Gustavo Lycurgo Leite, Leonardo Hadid, Dany David Kruczan, Ricardo Zajdenverg, Hugo de Castro Sabino, Paulo Antonio Marra da Motta
Summary: Severe tricuspid disease is now recognized as a significant contributor to cardiac morbidity and mortality, leading to the development of transcatheter procedures to manage the condition. The valve-in-valve procedure for the tricuspid valve has been shown to be feasible and safe, providing a new approach for patients who have undergone surgery and present with dysfunctional bioprostheses.
JOURNAL OF CLINICAL MEDICINE
(2021)
Article
Medicine, General & Internal
Besart Cuko, Massimo Baudo, Antoine Beurton, Olivier Busuttil, Mathieu Pernot
Summary: Post-transplant valve dysfunction is a common occurrence after orthotopic heart transplantation. Medical management is the first treatment option, but surgery, such as retransplantation, may be necessary when it fails. This case report describes a patient who developed severe aortic valve insufficiency and moderate-to-severe functional tricuspid valve insufficiency five years after cardiac transplant. The patient underwent aortic valve replacement and tricuspid valve repair with successful outcomes.
CUREUS JOURNAL OF MEDICAL SCIENCE
(2023)